<HashMap><database>biostudies-literature</database><scores/><additional><submitter>van Haren MJ</submitter><funding>European Research Council</funding><pagination>3806-3811</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7986777</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(11)</volume><pubmed_abstract>The increasing prevalence of metallo-β-lactamase (MBL)-expressing bacteria presents a worrying trend in antibiotic resistance. MBLs rely on active site zinc ions for their hydrolytic activity and the pursuit of MBL-inhibitors has therefore involved the investigation of zinc chelators. To ensure that such chelators specifically target MBLs, a series of cephalosporin prodrugs of two potent zinc-binders: dipicolinic acid (DPA) and 8-thioquinoline (8-TQ) was prepared. Although both DPA and 8-TQ bind free zinc very tightly (K&lt;sub>d&lt;/sub> values in the low nm range), the corresponding cephalosporin conjugates do not. The cephalosporin conjugates are efficiently hydrolyzed by MBLs to release DPA or 8-TQ, as confirmed by using both NMR and LC-MS studies. Notably, the cephalosporin prodrugs of DPA </pubmed_abstract><journal>Chemistry (Weinheim an der Bergstrasse, Germany)</journal><pubmed_title>Cephalosporin Prodrug Inhibitors Overcome Metallo-β-Lactamase Driven Antibiotic Resistance.</pubmed_title><pmcid>PMC7986777</pmcid><funding_grant_id>ERC consolidator grant (grant agreement no. 725523)</funding_grant_id><funding_grant_id>725523</funding_grant_id><pubmed_authors>Bruchle NC</pubmed_authors><pubmed_authors>Tehrani KHME</pubmed_authors><pubmed_authors>Wade N</pubmed_authors><pubmed_authors>van Haren MJ</pubmed_authors><pubmed_authors>Martin NI</pubmed_authors><pubmed_authors>Kotsogianni I</pubmed_authors><pubmed_authors>Mashayekhi V</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cephalosporin Prodrug Inhibitors Overcome Metallo-β-Lactamase Driven Antibiotic Resistance.</name><description>The increasing prevalence of metallo-β-lactamase (MBL)-expressing bacteria presents a worrying trend in antibiotic resistance. MBLs rely on active site zinc ions for their hydrolytic activity and the pursuit of MBL-inhibitors has therefore involved the investigation of zinc chelators. To ensure that such chelators specifically target MBLs, a series of cephalosporin prodrugs of two potent zinc-binders: dipicolinic acid (DPA) and 8-thioquinoline (8-TQ) was prepared. Although both DPA and 8-TQ bind free zinc very tightly (K&lt;sub>d&lt;/sub> values in the low nm range), the corresponding cephalosporin conjugates do not. The cephalosporin conjugates are efficiently hydrolyzed by MBLs to release DPA or 8-TQ, as confirmed by using both NMR and LC-MS studies. Notably, the cephalosporin prodrugs of DPA </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2025-04-27T01:16:36.204Z</modification><creation>2025-02-19T00:35:14.325Z</creation></dates><accession>S-EPMC7986777</accession><cross_references><pubmed>33237604</pubmed><doi>10.1002/chem.202004694</doi></cross_references></HashMap>